---
title: "CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China"
description: "CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/276051793.md"
published_at: "2026-02-16T10:56:34.000Z"
---

# CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China

### Related Stocks

- [516500.CN - ChinaAMC CSI Biotechnology Theme ETF](https://longbridge.com/en/quote/516500.CN.md)
- [513120.CN - GF CSI HK Innovative Drugs Industry ETF(QDII)](https://longbridge.com/en/quote/513120.CN.md)
- [512290.CN - Guotai CSI Bio-medicine ETF](https://longbridge.com/en/quote/512290.CN.md)
- [159316.CN - E Fund Hang Seng SCHK Innovative Drug ETF](https://longbridge.com/en/quote/159316.CN.md)
- [510660.CN - ChinaAMC SSE Health Care ETF Initiating Fund](https://longbridge.com/en/quote/510660.CN.md)
- [588130.CN - ChinaAMC SSE STAR Biology and Medicine ETF](https://longbridge.com/en/quote/588130.CN.md)
- [513700.CN - Penghua CSI HK Connect Health Care Composite ETF](https://longbridge.com/en/quote/513700.CN.md)
- [516930.CN - Minsheng Royal CSI Biotechnology Theme ETF](https://longbridge.com/en/quote/516930.CN.md)
- [520690.CN - Bosera Hang Seng SCHK Innovative Drug Select ETF](https://longbridge.com/en/quote/520690.CN.md)
- [512010.CN - E Fund CSI 300 Health Care ETF](https://longbridge.com/en/quote/512010.CN.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | [Link](https://longbridge.com/en/news/276035104.md) |
| Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$12.04 From HK$9.11, Keeps at Buy | Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$12.04 From HK$9.11, Keeps at Buy | [Link](https://longbridge.com/en/news/276056763.md) |
| AsymBio Launches Integrated Biopharma Platforms for End-to-End Development | AsymBio, a subsidiary of Asymchem Laboratories Tianjin Co. Ltd., has launched integrated technology platforms for the en | [Link](https://longbridge.com/en/news/275471539.md) |
| Sino Biopharmaceutical says NMPA approved Benmelstobart injection for marketing | Sino Biopharmaceutical says NMPA approved Benmelstobart injection for marketing | [Link](https://longbridge.com/en/news/276024005.md) |
| Beijing Tong Ren Tang Chinese Medicine Co. Ltd. Held Extraordinary General Meeting | Beijing Tong Ren Tang Chinese Medicine Co. Ltd. held an extraordinary general meeting on February 11, 2026, where all pr | [Link](https://longbridge.com/en/news/275583242.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.